Daily Signal · September 24, 2026

The Contract Has More Than One File

Before a regulator can decide whether a term is reasonable, the full bargain has to be recoverable as a reviewable record.

A reviewer examines blank records and binders in a pharmacy back office.
CMS request for informationPharmacy contract recordFuture standards

What changed

On September 24, CMS published a Request for Information about the contracts that connect Medicare Part D plans and network pharmacies. Congress has required the Department of Health and Human Services to establish standards for "reasonable and relevant" contract terms by the first Monday in April 2028, for plan years beginning January 1, 2029. This notice starts the evidence-gathering process. Comments close November 23.

That inquiry begins by locating the actual financial terms of an agreement. CMS names rate sheets, internal budget files, side letters, and unwritten understandings that may sit outside an executed contract. It asks whether provider manuals or policy bulletins modify the deal without a formal amendment. Then it follows the contract forward. How long does a pharmacy have to review the terms? Does silence count as acceptance? Does the pharmacy receive the reimbursement formula, fees, performance measures, and other payment details before it agrees?

Meanwhile, later questions move from acceptance to enforcement. CMS asks whether terms can change in the middle of a contract and whether a pharmacy can refuse those changes without losing its place in the network. It also seeks evidence about disputes and audits: who decides, how long resolution takes, what claim-level detail a pharmacy receives, whether an error can be corrected, and what documentation should eventually demonstrate compliance.

Why it matters

The result is that a signed contract can still be difficult to inspect when its working terms are scattered across files, later notices, and unwritten arrangements. That interpretation, drawn from the structure of CMS's questions rather than a finding in the notice, is the useful signal here. Before a regulator can decide whether a term is reasonable, the full bargain has to be recoverable as a reviewable record.

But the evidence boundary remains firm. CMS is gathering information about current practice, and its questions do not establish that a practice is common, unlawful, or harmful.

Meanwhile, the notice includes a smaller technology thread. CMS asks about machine learning used to estimate acquisition costs and about possible uses of AI in Part D reimbursement. Those are requests for information. CMS has not approved a particular system or created an AI requirement here.

Watch next

So watch the public comments for empirical analysis and de-identified contract language, both of which CMS requests. The later proposed standards will show whether the agency defines a complete contract record: which terms must be disclosed, how amendments are accepted, what dispute route must exist, and which documents prove compliance.

And common ownership is another live issue because the RFI asks respondents to consider vertical integration among plans, pharmacy benefit managers, and pharmacies. The rulemaking deadline is in 2028, and the structure of these questions points to the evidence work ahead: locating the terms, recording the changes, and connecting both to a review process.

Source

Caveat: This is an RFI for future rulemaking. It establishes no substantive standards and predicts no reimbursement, access, or beneficiary outcome. The card is informational and does not offer legal or contracting advice.